News

Moderna falls on doubts over new CDC panel's backing of RSV vaccine
Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...
FDA expands approval of Moderna's RSV vaccine to some adults under age 60
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects
The RSV shot, mRESVIA, secured U.S. approval on Thursday for expanded use in at-risk adults aged 18 to 59 years, but needs ...
FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness from ...
Spectrum News NY11d
CDC panel recommends Pfizer, Moderna vaccines over J&J shot, citing clotting concerns
A panel of advisers to the Centers for Disease Control and Prevention (CDC) unanimously voted Thursday to recommend the Pfizer-BioNTech or Moderna mRNA COVID-19 vaccines over Johnson & Johnson's ...
Northwest Asian Weekly1d
Dr. Helen Chu: CDC vaccine panel purge threatens public health
A leading infectious disease expert and one of the nation’s foremost COVID-19 researchers has voiced deep concerns about the ...